5,360
Views
61
CrossRef citations to date
0
Altmetric
Research Article

Effects of β-caryophyllene and Murraya paniculata essential oil in the murine hepatoma cells and in the bacteria and fungi 24-h time–kill curve studies

, , , , , & show all
Pages 190-197 | Received 08 Jun 2016, Accepted 27 Sep 2016, Published online: 07 Dec 2016

References

  • Abad MJ, Ansuategui M, Bermejo P. 2007. Active antifungal substances from natural sources. Arkivoc. 7:116–145.
  • Adams RP. 1995. Identification of essential oils components by gas chromatography/quadrupole mass spectroscopy. Carol Stream, IL: Allured Publishing Corporation.
  • Andrade MS, Ribeiro Ldo P, Borgoni PC, Silva MF, Forim MR, Fernandes JB, Vieira PC, Vendramin JD, Machado MA. 2016. Essential oil variation from twenty two genotypes of citrus in Brazil-chemometric approach and repellency against Diaphorina citri Kuwayama. Molecules. 21:2–10.
  • Bardaweel SK, Tawaha KA, Hudaib MM. 2014. Antioxidant, antimicrobial and antiproliferative activities of Anthemis palestina essential oil. BMC Complement Altern Med. 14:2971–2978.
  • Bayala B, Bassole IHN, Gnoula C, Nebie R, Yonli A, Morel L, Figueredo G, Nikiema JB, Lobaccaro JM, Simpore J. 2014. Chemical composition, antioxidant, anti-inflammatory and anti-proliferative activities of essential oils of plants from Burkina Faso. PLoS One. 9:92122.
  • Chowdhury JU, Bhuiyan MNI, Mohammed Y. 2008. Chemical composition of the leaf essential oils of Murraya koenigii (L.) Spreng and Murraya paniculata (L.) Jack. Bangla J Pharmacol. 3:59–63.
  • Clinical and Laboratory Standards Institute (CLSI) 1999. Methods for determining bactericidal activity of antimicrobial agents; approved guideline M26A; Approved standard, M26-A. Clinical and Laboratory Standards Institute, Wayne, PA.
  • Clinical and Laboratory Standards Institute (CLSI) 2002. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard, M38-A. Clinical and Laboratory Standards Institute, Wayne, PA.
  • Clinical and Laboratory Standards Institute (CLSI). 2005. Performance standards for antimicrobial susceptibility testing, 15th informational supplement, M100-S15. Wayne, PA.
  • Cos P, Vlietinck AJ, Berghe DV, Maes L. 2006 . Anti-infective potential of natural products: how to develop a stronger in vitro ‘proof-of-concept’. J Ethnopharmacol. 106:290–302.
  • Edris AE. 2007. Pharmaceutical and therapeutic potentials of essential oils and their individual volatile constituents: a review. Phytother Res. 21:308–323.
  • Fazal-ur-Rehman MFK, Khan I, Shareef H, Marwat SK. 2014. Analgesic activity of carbazole alkaloid from Murraya paniculata Linn. (Rutaceae). World Appl Sci J. 32:1631–1636.
  • Gautam MK, Gangwar M, Nath G, Rao CV, Goel RK. 2012a. In-vitro antibacterial activity on human pathogens and total phenolic, flavonoid contents of Murraya paniculata Linn. leaves. Asian Pac J Trop Biomed. 2:1660–1663.
  • Gautam MK, Gangwar M, Singh A, Rao CV, Goel RK. 2012b. In-vitro antioxidant properties of Murraya paniculata (L.) leaves extract. Inventi Impact: Ethnopharmacol. 2012:1–3.
  • Gobbo-Neto LNP. 2007. Plantas medicinais: fatores de influência no conteúdo de metabólitos secundários. Quim Nova. 30:374–381.
  • Holetz FB, Pessini GL, Sanches NR, Cortez DA, Nakamura CV, Filho BP. 2002. Screening of some plants used in the Brazilian folk medicine for the treatment of infectious diseases. Mem Inst Oswaldo Cruz. 97:1027–1031.
  • Lee Y. 2016. Cytotoxicity evaluation of essential oil and its component from Zingiber officinale Roscoe. Toxicol Res. 32:225–230.
  • Li WQ, Jiang CH, Chu SS, Zuo MX, Liu ZL. 2010. Chemical composition and toxicity against Sitophilus zeamais and Tribolium castaneum of the essential oil of Murraya exotica aerial parts. Molecules. 15:5831–5839.
  • Lv HN, Guo XY, Tu PF, Jiang Y. 2013. Comparative analysis of the essential oil composition of Murraya paniculata and M. exotica. Nat Prod Commun. 8:1473–1475.
  • Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 65:55–63.
  • Nkanwen ER, Gatsing D, Ngamga D, Fodouop SP, Tane P. 2009. Antibacterial agents from the leaves of Crinum purpurascens herb (Amaryllidaceae). Afr Health Sci. 9:264–269.
  • Raina VK, Verma SC, Dhawan SMK, Ramesh S, Singh SC, Yadav A, Srivastava SK. 2006. Essential oil composition of Murraya exotica from the plains of northern India. Flavour Fragr J. 21:140–142.
  • Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. 1999. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med. 26:1231–1237.
  • Rios JL, Recio MC. 2005. Medicinal plants and antimicrobial activity. J Ethnopharmacol. 100:80–84.
  • Rodanant P, Khetkam P, Suksamrarn A, Kuvatanasuchati J. 2015. Coumarins and flavonoid from Murraya paniculata (L.) Jack: antibacterial and anti-inflammation activity. Pak J Pharm Sci. 28:1947–1951.
  • Rodriguez EJ, Ramis-Ramos G, Heyden YV, Simó-Alfonso EF, Lerma-García MJ, Saucedo-Hernández Y, Monteagudo U, Morales Y, Holgado B, Herrero-Martínez JM. 2012. Chemical composition, antioxidant properties and antimicrobial activity of the essential oil of Murraya paniculata leaves from the mountains of Central Cuba. Nat Prod Commun. 7:1527–1530.
  • Saqib F, Ahmed MG, Janbaz KH, Dewanjee S, Jaafar HZ, Zia-Ul-Haq M. 2015. Validation of ethnopharmacological uses of Murraya paniculata in disorders of diarrhea, asthma and hypertension. BMC Complement Altern Med. 15:3191–3198.
  • Scherer R, Godoy HT. 2009. Antioxidant activity index (AAI) by the 2, 2-diphenyl-1-picrylhydrazyl method. Food Chem. 112:654–658.
  • Shah S, Saied S, Mahmood A, Malik A. 2014. Phytochemical screening of volatile constituents from aerial parts of Murraya paniculata. Pak J Bot. 46:2051–2056.
  • Suffness M, Pezzuto JM. 1991. Assays related to cancer drug discovery. In: Methods in plant biochemistry, Vol. 6. New York: Academic Press; p. 92.
  • Sumathy V, Zakaria Z, Jothy SL, Gothai S, Vijayarathna S, Yoga LL, Chen Y, Sasidharan S. 2014. In vitro and in vivo antifungal activity of Cassia surattensis flower against Aspergillus niger. Microb Pathog. 77:7–12.
  • Sundaram M. 2011. Studies on in vitro antibacterial, antifungal property and antioxidant potency of Murraya paniculata. Pak J Nutr. 10:925–929.
  • Teshima N, Manabe Y, Tada T, Arakawa R, Ban S, Okasyo F, Ju-ichi M, Furukawa H, Ito C. 2014. Coumarins from the leaves of Murraya paniculata collected at Iriomote Island. Jpn. J Pharmacogn. 68:25–26.
  • World Health Organization. 2002. Traditional medicine strategy 2002–2005. Geneva: WHO.
  • Wu J, Liu K, Shi X. 2016. The anti-inflammatory activity of several flavonoids isolated from Murraya paniculata on murine macrophage cell line and gastric epithelial cell (GES-1). Pharm Biol. 54:868–881.
  • Wu L, Li P, Wang X, Zhuang Z, Farzaneh F, Xu R. 2010. Evaluation of anti-inflammatory and antinociceptive activities of Murraya exotica. Pharm Biol. 48:1344–1353.
  • Zhang JY, Li N, Che YY, Zhang Y, Liang SX, Zhao MB, Jiang Y, Tu PF. 2011. Characterization of seventy polymethoxylated flavonoids (PMFs) in the leaves of Murraya paniculata by on-line high-performance liquid chromatography coupled to photodiode array detection and electrospray tandem mass spectrometry. J Pharm Biomed Anal. 56:950–961.
  • Zou J, Yu X, Qu S, Li X, Jin Y, Sui D. 2014. Protective effect of total flavonoids extracted from the leaves of Murraya paniculata (L.) Jack on diabetic nephropathy in rats. Food Chem Toxicol. 64:231–237.